BiOrion Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
BiOrion General Information
Description
Developer of radiopharmaceuticals, radiotherapeutics, and imaging diagnostics designed to treat patients with fibrosis and fibrotic cancer. The company's tracers are based on single-domain antibodies recognizing the extracellular domains of the membrane receptors of activated myofibroblasts, the key pathogenic cells in lung fibrosis, cardiac fibrosis, kidney fibrosis, hepatic fibrosis, and fibrotic cancers such as colon cancer, enabling healthcare professionals to diagnose and treat patients with high medical need and urgency.
Contact Information
Website
www.biorion.comCorporate Office
- MediTech Center
- L.J. Zielstraweg 1
- 9713 GX Groningen
- Netherlands
Corporate Office
- MediTech Center
- L.J. Zielstraweg 1
- 9713 GX Groningen
- Netherlands
BiOrion Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 01-Jul-2023 | Completed | Clinical Trials - Phase 2 | |||
| 15. IPO | Cancelled | Clinical Trials - Phase 2 | ||||
| 14. Later Stage VC | Cancelled | Clinical Trials - Phase 2 | ||||
| 13. Later Stage VC (Series A) | Cancelled | Clinical Trials - Phase 2 | ||||
| 12. Later Stage VC | Completed | Clinical Trials - Phase 2 | ||||
| 11. Later Stage VC | 22-Feb-2022 | Completed | Clinical Trials - Phase 2 | |||
| 10. Grant | 22-Apr-2021 | Completed | Clinical Trials - Phase 2 | |||
| 9. Later Stage VC | 20-Feb-2019 | Completed | Clinical Trials - Phase 1 | |||
| 8. Later Stage VC | 19-Feb-2019 | $264K | $2.44M | Completed | Pre-Clinical Trials | |
| 7. Grant | 14-Sep-2017 | $571K | $2.18M | Completed | Pre-Clinical Trials |
BiOrion Comparisons
Industry
Financing
Details
BiOrion Competitors (45)
One of BiOrion’s 45 competitors is Blue Earth Diagnostics, a Formerly VC-backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Blue Earth Diagnostics | Formerly VC-backed | Oxford, United Kingdom | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Regenerx | Formerly VC-backed | Rockville, MD | ||||
| Cullinan Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA |
BiOrion Patents
BiOrion Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4100437-A1 | Platelet derived growth factor receptor (pdgfr) antibodies, conjugates, compositions, and uses thereof | Inactive | 07-Feb-2020 | ||
| US-20240174755-A1 | Platelet derived growth factor receptor (pdgfr) antibodies, conjugates, compositions, and uses thereof | Inactive | 07-Feb-2020 | ||
| WO-2021158110-A1 | Platelet derived growth factor receptor (pdgfr) antibodies, conjugates, compositions, and uses thereof | Inactive | 07-Feb-2020 | ||
| CA-3170712-A1 | Platelet derived growth factor receptor (pdgfr) antibodies, conjugates, compositions, and uses thereof. | Pending | 07-Feb-2020 | ||
| US-10442845-B2 | Interferon analogs | Inactive | 10-Feb-2010 | A61K38/217 |
BiOrion Signals
BiOrion Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Carduso Capital | Venture Capital | Minority | ||
| European Commission | Government | Minority | ||
| Eurostars | Other | Minority | ||
| GJ Smid Fonds | Venture Capital | Minority | ||
| Hanzepoort | Venture Capital | Minority |
BiOrion FAQs
-
When was BiOrion founded?
BiOrion was founded in 2007.
-
Where is BiOrion headquartered?
BiOrion is headquartered in Groningen, Netherlands.
-
What is the size of BiOrion?
BiOrion has 4 total employees.
-
What industry is BiOrion in?
BiOrion’s primary industry is Drug Discovery.
-
Is BiOrion a private or public company?
BiOrion is a Private company.
-
What is BiOrion’s current revenue?
The current revenue for BiOrion is .
-
How much funding has BiOrion raised over time?
BiOrion has raised $5.92M.
-
Who are BiOrion’s investors?
Carduso Capital, European Commission, Eurostars, GJ Smid Fonds, and Hanzepoort are 5 of 8 investors who have invested in BiOrion.
-
Who are BiOrion’s competitors?
Blue Earth Diagnostics, Inovio Pharmaceuticals, Regenerx, Cullinan Therapeutics, and Kite Pharma are some of the 45 competitors of BiOrion.
-
When was BiOrion acquired?
BiOrion was acquired on 01-Jul-2023.
-
Who acquired BiOrion?
BiOrion was acquired by Cortalix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process